BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 28580827)

  • 1. Therapeutic management of acute pulmonary embolism.
    Tromeur C; Van Der Pol LM; Couturaud F; Klok FA; Huisman MV
    Expert Rev Respir Med; 2017 Aug; 11(8):641-648. PubMed ID: 28580827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological management of pulmonary embolism.
    Gouin B; Robert-Ebadi H; Righini M; Blondon M
    Expert Opin Pharmacother; 2017 Jan; 18(1):79-93. PubMed ID: 27917690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute pulmonary embolism: risk assessment, risk stratification and treatment options.
    Piovella F; Iosub DI
    Clin Respir J; 2016 Sep; 10(5):545-54. PubMed ID: 25619266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulant treatment of pulmonary embolism: impact and implications of the EINSTEIN PE study.
    Prandoni P
    Eur J Haematol; 2012 Oct; 89(4):281-7. PubMed ID: 22834998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-vitamin K oral anticoagulants versus vitamin K antagonists in the treatment of venous thromboembolic disease.
    Voukalis C; Lip GY; Shantsila E
    Expert Opin Pharmacother; 2016 Oct; 17(15):2033-47. PubMed ID: 27667112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Managing pulmonary embolism from presentation to extended treatment.
    Cohen AT; Dobromirski M; Gurwith MM
    Thromb Res; 2014 Feb; 133(2):139-48. PubMed ID: 24182642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of venous thrombo-embolism: an update.
    Konstantinides S; Torbicki A
    Eur Heart J; 2014 Nov; 35(41):2855-63. PubMed ID: 25179762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses.
    Almutairi AR; Zhou L; Gellad WF; Lee JK; Slack MK; Martin JR; Lo-Ciganic WH
    Clin Ther; 2017 Jul; 39(7):1456-1478.e36. PubMed ID: 28668628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct oral anticoagulants as alternative treatment options for the effective long-term treatment of patients with pulmonary embolism in primary care: a review.
    Toth PP
    Ann Med; 2014 Sep; 46(6):341-52. PubMed ID: 24888386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pulmonary embolism and direct oral anticoagulants].
    Olschewski H
    Wien Med Wochenschr; 2018 Apr; 168(5-6):144-147. PubMed ID: 26983621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct oral anticoagulants in the treatment of venous thromboembolism, with a focus on patients with pulmonary embolism: an evidence-based review.
    Gómez-Outes A; Suárez-Gea ML; Lecumberri R; Terleira-Fernández AI; Vargas-Castrillón E
    Vasc Health Risk Manag; 2014; 10():627-39. PubMed ID: 25404858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contemporary anticoagulant treatment strategies in patients with acute pulmonary embolism at different risk for death.
    Becattini C; Agnelli G; Diamanti M; Maggioni AP; Vanni S; Dentali F; Enea I; Bortolotti P; De Vecchi M; Artusi N; Picariello C; Nitti C; Lucci D; Gulizia MM;
    Vascul Pharmacol; 2023 Dec; 153():107245. PubMed ID: 38013135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis, prognosis and therapeutic management of acute pulmonary embolism.
    Tapson VF
    Hosp Pract (1995); 2016 Aug; 44(3):164-72. PubMed ID: 27450108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute phase treatment of VTE: Anticoagulation, including non-vitamin K antagonist oral anticoagulants.
    Hillis C; Crowther MA
    Thromb Haemost; 2015 Jun; 113(6):1193-202. PubMed ID: 25948149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early, real-world experience with direct oral anticoagulants in the treatment of intermediate-high risk acute pulmonary embolism.
    Santos SM; Cunha S; Baptista R; Monteiro S; Monteiro P; Gonçalves F; Pêgo M
    Rev Port Cardiol; 2017 Nov; 36(11):801-806. PubMed ID: 29126891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct oral anticoagulants in the treatment of pulmonary embolism.
    Eldredge JB; Spyropoulos AC
    Curr Med Res Opin; 2018 Jan; 34(1):131-140. PubMed ID: 28771049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute phase treatment of pulmonary embolism.
    Chalikias G; Konstantinides S
    Curr Vasc Pharmacol; 2014 May; 12(3):393-400. PubMed ID: 24846228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A meta-analysis of outcomes of catheter-directed thrombolysis for high- and intermediate-risk pulmonary embolism.
    Avgerinos ED; Saadeddin Z; Abou Ali AN; Fish L; Toma C; Chaer M; Rivera-Lebron BN; Chaer RA
    J Vasc Surg Venous Lymphat Disord; 2018 Jul; 6(4):530-540. PubMed ID: 29909859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct Oral Anticoagulants for Pulmonary Embolism.
    Pizzi R; Cimini LA; Ageno W; Becattini C
    Hamostaseologie; 2024 Jun; 44(3):206-217. PubMed ID: 38467144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treating patients with cancer and acute venous thromboembolism.
    Donadini MP; Squizzato A; Ageno W
    Expert Opin Pharmacother; 2016; 17(4):535-43. PubMed ID: 26606049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.